CMS released an update to its FAQ on coding and billing for the novel coronavirus (COVID-19) on March 23. The FAQ clarifies the use of HCPCS and CPT® codes for diagnostic laboratory services.
CMS announced blanket waivers of certain Medicare requirements to prevent gaps in care for beneficiaries affected by the novel coronavirus (COVID-19) public health emergency. The agency released billing instructions and a set of Q&As.
CMS provided updated coding and billing information in its Clinical Laboratory Fee Schedule (CLFS) for organizations performing tests for COVID-19 and providing treatment for confirmed or suspected COVID-19 infections.
National Correct Coding Initiative (NCCI) edits can be a major stumbling block in the billing process. Take a look at the different types of NCCI edits and strategies to address them.
To enhance efforts to combat the opioid crisis in America, CMS policy allows for a new benefit under Medicare Part B concerning Opioid Treatment Programs.
The Centers for Disease Control and Prevention (CDC) is monitoring the rapid spread of a novel 2019 coronavirus, formally named COVID-19, first identified in Wuhan, Hubei Province, China. On January 30, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern due to its sustained person-to-person spread within countries and across continental borders.
